• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Multiply robust estimators in longitudinal studies with missing data under control-based imputation.基于控制插补法的纵向研究中缺失数据的多重稳健估计量
Biometrics. 2024 Jan 29;80(1). doi: 10.1093/biomtc/ujad036.
2
Handling intercurrent events and missing data in non-inferiority trials using the estimand framework: A tuberculosis case study.使用估计量框架处理非劣效性试验中的并发事件和缺失数据:一个结核病案例研究。
Clin Trials. 2023 Oct;20(5):497-506. doi: 10.1177/17407745231176773. Epub 2023 Jun 5.
3
Double Robust Efficient Estimators of Longitudinal Treatment Effects: Comparative Performance in Simulations and a Case Study.纵向治疗效果的双重稳健有效估计量:模拟中的比较性能及一个案例研究
Int J Biostat. 2019 Feb 26;15(2):/j/ijb.2019.15.issue-2/ijb-2017-0054/ijb-2017-0054.xml. doi: 10.1515/ijb-2017-0054.
4
Sensitivity analyses in longitudinal clinical trials via distributional imputation.基于分布推断的纵向临床试验中的敏感性分析。
Stat Methods Med Res. 2023 Jan;32(1):181-194. doi: 10.1177/09622802221135251. Epub 2022 Nov 6.
5
Aligning Estimators With Estimands in Clinical Trials: Putting the ICH E9(R1) Guidelines Into Practice.临床试验中估算值与目标值的一致性:实践 ICH E9(R1) 指导原则。
Ther Innov Regul Sci. 2020 Mar;54(2):353-364. doi: 10.1007/s43441-019-00063-9. Epub 2020 Jan 6.
6
Estimating the treatment effect for adherers using multiple imputation.使用多重填补法估计依从者的治疗效果。
Pharm Stat. 2022 May;21(3):525-534. doi: 10.1002/pst.2184. Epub 2021 Dec 19.
7
Estimation of treatment effects in short-term depression studies. An evaluation based on the ICH E9(R1) estimands framework.短期抑郁症研究中治疗效果的评估。基于 ICH E9(R1)评价指标框架的评估。
Pharm Stat. 2022 Sep;21(5):1037-1057. doi: 10.1002/pst.2214. Epub 2022 Jun 9.
8
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
9
Incorporating estimands into clinical trial statistical analysis plans.将估计量纳入临床试验统计分析计划中。
Clin Trials. 2022 Jun;19(3):285-291. doi: 10.1177/17407745221080463. Epub 2022 Mar 8.
10
Doubly robust estimation in missing data and causal inference models.缺失数据与因果推断模型中的双重稳健估计
Biometrics. 2005 Dec;61(4):962-73. doi: 10.1111/j.1541-0420.2005.00377.x.

本文引用的文献

1
Robust analyzes for longitudinal clinical trials with missing and non-normal continuous outcomes.针对具有缺失和非正态连续结局的纵向临床试验的稳健分析。
Stat Theory Relat Fields. 2024;8(1):1-14. doi: 10.1080/24754269.2023.2261351. Epub 2023 Sep 26.
2
Sensitivity analyses in longitudinal clinical trials via distributional imputation.基于分布推断的纵向临床试验中的敏感性分析。
Stat Methods Med Res. 2023 Jan;32(1):181-194. doi: 10.1177/09622802221135251. Epub 2022 Nov 6.
3
Improving trial generalizability using observational studies.利用观察性研究提高试验的概括性。
Biometrics. 2023 Jun;79(2):1213-1225. doi: 10.1111/biom.13609. Epub 2022 Jan 11.
4
SMIM: A unified framework of survival sensitivity analysis using multiple imputation and martingale.SMIM:使用多重插补和鞅方法的生存敏感性分析的统一框架。
Biometrics. 2023 Mar;79(1):230-240. doi: 10.1111/biom.13555. Epub 2021 Sep 20.
5
A review of the use of controlled multiple imputation in randomised controlled trials with missing outcome data.缺失结局数据的随机对照试验中使用控制多重填补的综述。
BMC Med Res Methodol. 2021 Apr 15;21(1):72. doi: 10.1186/s12874-021-01261-6.
6
Framework for the treatment and reporting of missing data in observational studies: The Treatment And Reporting of Missing data in Observational Studies framework.观察性研究中缺失数据的处理和报告框架:观察性研究中缺失数据的处理和报告框架。
J Clin Epidemiol. 2021 Jun;134:79-88. doi: 10.1016/j.jclinepi.2021.01.008. Epub 2021 Feb 2.
7
Sensitivity analysis for clinical trials with missing continuous outcome data using controlled multiple imputation: A practical guide.使用对照多重填补法对具有缺失连续结局数据的临床试验进行敏感性分析:实用指南。
Stat Med. 2020 Sep 20;39(21):2815-2842. doi: 10.1002/sim.8569. Epub 2020 May 17.
8
Improving Study Conduct and Data Quality in Clinical Trials of Chronic Pain Treatments: IMMPACT Recommendations.改善慢性疼痛治疗临床试验的研究实施和数据质量:IMMPACT 建议。
J Pain. 2020 Sep-Oct;21(9-10):931-942. doi: 10.1016/j.jpain.2019.12.003. Epub 2019 Dec 13.
9
A causal modelling framework for reference-based imputation and tipping point analysis in clinical trials with quantitative outcome.一种基于因果建模的方法,用于临床试验中具有定量结局的参考赋值和临界点分析。
J Biopharm Stat. 2020 Mar;30(2):334-350. doi: 10.1080/10543406.2019.1684308. Epub 2019 Nov 12.
10
Recent Developments in the Prevention and Treatment of Missing Data.缺失数据预防与治疗的最新进展
Ther Innov Regul Sci. 2014 Jan;48(1):68-80. doi: 10.1177/2168479013501310.

基于控制插补法的纵向研究中缺失数据的多重稳健估计量

Multiply robust estimators in longitudinal studies with missing data under control-based imputation.

作者信息

Liu Siyi, Yang Shu, Zhang Yilong, Liu Guanghan Frank

机构信息

Department of Statistics, North Carolina State University, Raleigh, NC 27607, United States.

Merck & Co., Inc., Kenilworth, NJ 07033, United States.

出版信息

Biometrics. 2024 Jan 29;80(1). doi: 10.1093/biomtc/ujad036.

DOI:10.1093/biomtc/ujad036
PMID:38393335
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10885818/
Abstract

Longitudinal studies are often subject to missing data. The recent guidance from regulatory agencies, such as the ICH E9(R1) addendum addresses the importance of defining a treatment effect estimand with the consideration of intercurrent events. Jump-to-reference (J2R) is one classical control-based scenario for the treatment effect evaluation, where the participants in the treatment group after intercurrent events are assumed to have the same disease progress as those with identical covariates in the control group. We establish new estimators to assess the average treatment effect based on a proposed potential outcomes framework under J2R. Various identification formulas are constructed, motivating estimators that rely on different parts of the observed data distribution. Moreover, we obtain a novel estimator inspired by the efficient influence function, with multiple robustness in the sense that it achieves n1/2-consistency if any pairs of multiple nuisance functions are correctly specified, or if the nuisance functions converge at a rate not slower than n-1/4 when using flexible modeling approaches. The finite-sample performance of the proposed estimators is validated in simulation studies and an antidepressant clinical trial.

摘要

纵向研究常常会遇到数据缺失的情况。监管机构近期发布的指南,如国际人用药品注册技术协调会(ICH)E9(R1)增编,阐述了在考虑并发事件的情况下定义治疗效果估计量的重要性。跳转到参照组(J2R)是治疗效果评估中一种基于对照的经典场景,在这种场景下,并发事件发生后治疗组中的参与者被假定与对照组中具有相同协变量的参与者具有相同的疾病进展。我们基于J2R下提出的潜在结果框架建立了新的估计量,以评估平均治疗效果。构建了各种识别公式,从而激发了依赖于观测数据分布不同部分的估计量。此外,我们得到了一个受有效影响函数启发的新估计量,它具有多重稳健性,即如果多个干扰函数中的任意一对被正确设定,或者在使用灵活建模方法时干扰函数以不慢于n^(-1/4)的速率收敛,那么它能实现n^(1/2) - 一致性。在模拟研究和一项抗抑郁药物临床试验中验证了所提出估计量的有限样本性能。